Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Roeland Zoutendijk"'
Publikováno v:
Endoscopy. 54:E98-E99
Autor:
Margo J. H. van Campenhout, Andre Boonstra, Andrea M. Woltman, Harry L.A. Janssen, Jurriën G.P. Reijnders, Roeland Zoutendijk, Lauke L. Boeijen, Eric T.T.L. Tjwa, Gertine W. van Oord, Robert J. de Knegt
Publikováno v:
Antiviral Research, 132, 70-5
Antiviral Research, 132, pp. 70-5
Antiviral Research, 132, 70-75. Elsevier
Antiviral Research, 132, pp. 70-5
Antiviral Research, 132, 70-75. Elsevier
Background: Currently, much effort is directed at further improving treatment for chronic hepatitis B patients by assessing the effect of immunomodulatory agents during therapy with nucleotide analogues (NUC). Although there are some reports on the e
Publikováno v:
Endoscopy, 51(8), E205-E206. Georg Thieme Verlag
Autor:
Teresa Santantonio, Bettina E. Hansen, Tania M. Welzel, Harry L.A. Janssen, Robert J. de Knegt, Maria Buti, Pauline Arends, Ivana Carey, Y.H. Oo, Roeland Zoutendijk, Katja Deterding, Massimo Fasano, Thomas Berg, David Mutimer, Ashley Brown, Milan J. Sonneveld, Jörg Petersen, Florian van Bömmel, Pierre Pradat, Fabien Zoulim, Heiner Wedemeyer, Jurriën G.P. Reijnders
Publikováno v:
Gut, 64(8), 1289-1295. BMJ Publishing Group
Background Hepatocellular carcinoma (HCC) risk-scores may predict HCC in Asian entecavir (ETV)-treated patients. We aimed to study risk factors and performance of risk scores during ETV treatment in an ethnically diverse Western population. Methods W
Autor:
Harry L.A. Janssen, Stefan Zeuzem, Krzysztof Simon, Ulus Salih Akarca, Louwerens Zwang, Vincent Rijckborst, Milan J. Sonneveld, Roeland Zoutendijk, Bettina E. Hansen, E. Jenny Heathcote, Suzan D. Pas
Publikováno v:
Antiviral Research, 97(3), 312-317. Elsevier
Hepatitis B e antigen (HBeAg) levels may predict response to peginterferon (PEG-IFN) but are also influenced by presence of precore (PC) and core promoter (BCP) mutants. HBeAg was measured in 214 patients treated with PEG-IFN±lamivudine for 52weeks.
Autor:
Ashley Brown, Joerg Petersen, Harry L.A. Janssen, Massimo Fasano, Thomas Berg, Heiner Wedemeyer, Katja Deterding, Milan J. Sonneveld, Bettina E. Hansen, David Mutimer, Maria Buti, Fabien Zoulim, Jurriën G.P. Reijnders, Roeland Zoutendijk, Wolf Peter Hofmann
Publikováno v:
Gut, 62(5), 760-765. BMJ Publishing Group
Entecavir (ETV) is a potent inhibitor of viral replication in chronic hepatitis B and prolonged treatment may result in regression of fibrosis. The aim of this study was to investigate the effect of ETV on disease progression.In a multicentre cohort
Publikováno v:
Antiviral Therapy. 17:1605-1608
Background Hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) clearance are associated with an improved prognosis in chronic hepatitis B (CHB) patients. These end points are more often achieved with a one-year course of pegylated i
Autor:
Hajo J. Flink, Louwerens Zwang, Bettina E. Hansen, Roeland Zoutendijk, Milan J. Sonneveld, Harry L.A. Janssen
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 56(1), 100-105. Oxford University Press
Clinical Infectious Diseases, 56(1), 100-105. Oxford University Press
Host-induced flares are associated with presence of only wild-type hepatitis B virus (HBV) and result in decline and clearance of HBV DNA, hepatitis B e antigen, and hepatitis B surface antigen (HBsAg). Monitoring of HBsAg levels during and after fla
Autor:
Hans L. Zaaijer, Roeland Zoutendijk, Annemiek A. van der Eijk, Clemens Richter, Jan W. Mulder, Harry L.A. Janssen, Marchina E. van der Ende, Jurriën G.P. Reijnders, Milan J. Sonneveld, Robert A. de Man, Frank P. Kroon, Bettina E. Hansen, Theodora E. M. S. de Vries-Sluijs
Publikováno v:
Journal of Infectious Diseases, 206(6), 974-980. Oxford University Press
Journal of infectious diseases, 206(6), 974-980. Oxford University Press
Journal of infectious diseases, 206(6), 974-980. Oxford University Press
Background.The kinetics of hepatitis B surface antigen (HBsAg) are predictive in HBV-infected patients treated with pegylated interferon. Knowledge about the value of HBsAg levels in patients coinfected with HBV and human immunodeficiency virus (HIV)
Autor:
Fabien Zoulim, Heiner Wedemeyer, Roeland Zoutendijk, Rafael Esteban, Jérôme Dumortier, Maria Buti, Si-Nafa Si-Ahmed, Katja Deterding, Vincent Mallet, Claire Cruiziat, Pierre Pradat, François Bailly, Harry L.A. Janssen
Publikováno v:
Antiviral Research, 92(1), 90-95. Elsevier
Background and aims: The combination of tenofovir disoproxil fumarate (TDF) plus emtricitabine (FTC) is used extensively to treat HIV infection and also has potent activity against hepatitis B virus (HBV) infection. The aim of this study was to asses